Transaction · 0000914190-26-000171

Hippel James

Hippel James, CFO, reported a transaction classified as return at BIO-TECHNE Corp involving 12798.000000 shares for an estimated $0.00. Reported holdings after the transaction were 0.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

returnSEC transaction code DCFO
TECHBIO-TECHNE Corp
Trade date
Aug 15, 2026
Filing date
Nov 02, 2026
View on SEC Insider profile
Disclosed value$0Shares × reported price
Shares traded12.7k$0.00 per share
Holdings after0Direct
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Filing warnings

Notes recorded with this filing
2 warnings
amended filingThis transaction comes from an amended Form 4 filing.
delayed filingThe filing was reported 79 calendar days after the transaction date.

TECH price since this filing

Daily closing prices, with the filing date and available return windows
TECH · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -2.3%1w ago -0.5%1d ago -0.4%
Returns since7d30d90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
return
Code D
Identifier
0000914190-26-000171
Performance Restricted Stock Units
Transaction date
Aug 15, 2026
Filed Nov 02, 2026, 09:40 PM · 79d delay
Shares
12,798 sh
$0.00 per share
Estimated value
$0
Computed from shares × price
Holdings after
0 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Amended Filing Delayed Filing Derivative Transaction Direct Ownership
Filing-only score

-22 points

Compact filing score computed from stored Form 4 facts. Version v1.

Low filing signal

This filing has a meaningfully negative filing-only score. It is likely less useful as a positive insider-activity signal.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • derivative_transaction-16 points

    is_derivative = true

    Derivative exercise rows are less discretionary than open-market purchases.
  • amended_filing-6 points

    is_amendment = true

    Amended filing: the original transaction may have been restated.
  • delayed_filing-6 points

    reporting_delay_days = 79

    Filing delay exceeds the configured threshold.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

CFO

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    On 8/15/2026, the Board of Directors authorized discretionary vesting for 2,871 performance options. The remainder of the performance options were forfeited.

  2. F2

    Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock.

  3. F3

    On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,067 performance RSUs. The remainder of the performance RSUs were forfeited.

  4. F4

    4,010 restricted stock units vest on 8/15/2026; and 4,011 restricted stock units vest on 8/15/2027.

  5. F5

    4,903 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 4,904 restricted stock units vest on 8/15/2028.

Amended filing · 0000914190-26-000171
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

TECH